Published in BMC Bioinformatics on July 03, 2014
Comprehensive assessment of cancer missense mutation clustering in protein structures. Proc Natl Acad Sci U S A (2015) 1.06
Functional consequences of somatic mutations in cancer using protein pocket-based prioritization approach. Genome Med (2014) 0.84
DriverDBv2: a database for human cancer driver gene research. Nucleic Acids Res (2015) 0.81
3D clusters of somatic mutations in cancer reveal numerous rare mutations as functional targets. Genome Med (2017) 0.77
Leveraging protein quaternary structure to identify oncogenic driver mutations. BMC Bioinformatics (2016) 0.75
Comparison of algorithms for the detection of cancer drivers at subgene resolution. Nat Methods (2017) 0.75
A method and server for predicting damaging missense mutations. Nat Methods (2010) 78.53
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med (2004) 71.08
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
The consensus coding sequences of human breast and colorectal cancers. Science (2006) 60.02
Patterns of somatic mutation in human cancer genomes. Nature (2007) 38.41
p53 mutations in human cancers. Science (1991) 31.96
Predicting deleterious amino acid substitutions. Genome Res (2001) 28.95
Cancer genes and the pathways they control. Nat Med (2004) 24.22
Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res (2011) 18.50
Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res (2011) 10.99
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature (2002) 7.46
Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature (2008) 6.80
Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov (2006) 5.99
Mutational analysis of the tyrosine kinome in colorectal cancers. Science (2003) 5.43
Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. Cancer Res (2009) 4.92
Mechanisms of disease: Oncogene addiction--a rationale for molecular targeting in cancer therapy. Nat Clin Pract Oncol (2006) 4.47
Suppression of BRAF(V599E) in human melanoma abrogates transformation. Cancer Res (2003) 4.28
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature (2012) 3.83
The expected equilibrium of the CpG dinucleotide in vertebrate genomes under a mutation model. Proc Natl Acad Sci U S A (1990) 3.56
Methods to detect selection in populations with applications to the human. Annu Rev Genomics Hum Genet (2000) 3.45
Prevalence of somatic alterations in the colorectal cancer cell genome. Proc Natl Acad Sci U S A (2002) 3.25
Proteasome inhibitors in multiple myeloma: 10 years later. Blood (2012) 2.77
Identifying cancer driver genes in tumor genome sequencing studies. Bioinformatics (2010) 2.52
Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. Cancer Res (1999) 2.18
Tyrosine kinase inhibitors - a review on pharmacology, metabolism and side effects. Curr Drug Metab (2009) 2.17
Crystal structures of anaplastic lymphoma kinase in complex with ATP competitive inhibitors. Biochemistry (2010) 1.94
Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents. Clin Cancer Res (2012) 1.92
Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF. Sci Signal (2011) 1.90
Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice. J Clin Invest (2009) 1.89
Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J Clin Invest (2006) 1.78
An atlas of chaperone-protein interactions in Saccharomyces cerevisiae: implications to protein folding pathways in the cell. Mol Syst Biol (2009) 1.75
Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity. Proc Natl Acad Sci U S A (2004) 1.70
Prediction of cancer driver mutations in protein kinases. Cancer Res (2008) 1.59
Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1). Hum Mol Genet (1996) 1.50
Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation. Mol Biol Cell (2001) 1.36
ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth. J Cell Sci (2004) 1.34
Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity. Oncogene (1999) 1.22
Detection of BRAF V600E mutation by pyrosequencing. Pathology (2008) 1.16
BRAF mutations in non-Hodgkin's lymphoma. Br J Cancer (2003) 1.13
The constitutive activity of the ALK mutated at positions F1174 or R1275 impairs receptor trafficking. Oncogene (2011) 1.06
Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases. BMC Cancer (2013) 1.05
Statistical method on nonrandom clustering with application to somatic mutations in cancer. BMC Bioinformatics (2010) 0.97
Utilizing protein structure to identify non-random somatic mutations. BMC Bioinformatics (2013) 0.96
Rapid detection of positive selection in genes and genomes through variation clusters. Genetics (2007) 0.95
A graph theoretic approach to utilizing protein structure to identify non-random somatic mutations. BMC Bioinformatics (2014) 0.91
Treatment of ALK-positive non-small cell lung cancer. Arch Pathol Lab Med (2012) 0.90
Design and optimization of potent and orally bioavailable tetrahydronaphthalene Raf inhibitors. J Med Chem (2011) 0.90
Detecting clusters of mutations. PLoS One (2008) 0.84
FGFR3-targeted mAb therapy for bladder cancer and multiple myeloma. J Clin Invest (2009) 0.81
Non-neuronal functions of the m2 muscarinic acetylcholine receptor. Genes (Basel) (2013) 0.80
M2 receptor activation inhibits cell cycle progression and survival in human glioblastoma cells. J Cell Mol Med (2013) 0.80
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13
De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature (2012) 13.61
X-ray structure of a protein-conducting channel. Nature (2003) 9.20
The BioPAX community standard for pathway data sharing. Nat Biotechnol (2010) 9.19
Subcellular localization of the yeast proteome. Genes Dev (2002) 7.93
De novo mutations in histone-modifying genes in congenital heart disease. Nature (2013) 5.15
Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol (2006) 5.09
A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res (2008) 5.05
On a semiparametric test to detect associations between quantitative traits and candidate genes using unrelated individuals. Genet Epidemiol (2003) 4.67
Laparotomy versus peritoneal drainage for necrotizing enterocolitis and perforation. N Engl J Med (2006) 4.60
Advancing translational research with the Semantic Web. BMC Bioinformatics (2007) 4.38
Analysis of transcription factor HY5 genomic binding sites revealed its hierarchical role in light regulation of development. Plant Cell (2007) 4.13
Association mapping, using a mixture model for complex traits. Genet Epidemiol (2002) 3.95
An integrated approach for finding overlooked genes in yeast. Nat Biotechnol (2002) 3.88
Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data. Bioinformatics (2003) 3.78
Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res (2004) 3.64
Serum protein markers for early detection of ovarian cancer. Proc Natl Acad Sci U S A (2005) 3.22
Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice. Nat Cell Biol (2003) 3.05
A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis. Lancet Oncol (2011) 2.95
BGI-RIS: an integrated information resource and comparative analysis workbench for rice genomics. Nucleic Acids Res (2004) 2.69
Genetic analysis of variation in transcription factor binding in yeast. Nature (2010) 2.69
ALFRED: An allele frequency database for anthropology. Am J Phys Anthropol (2002) 2.67
A transcriptome atlas of rice cell types uncovers cellular, functional and developmental hierarchies. Nat Genet (2009) 2.53
Strong association of the alcohol dehydrogenase 1B gene (ADH1B) with alcohol dependence and alcohol-induced medical diseases. Biol Psychiatry (2011) 2.45
A statistical method for identifying differential gene-gene co-expression patterns. Bioinformatics (2004) 2.23
Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes. J Virol (2006) 2.20
HAPLORE: a program for haplotype reconstruction in general pedigrees without recombination. Bioinformatics (2004) 2.16
A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk. Cancer Res (2010) 2.15
Genomewide linkage scan for opioid dependence and related traits. Am J Hum Genet (2006) 2.15
Information assessment on predicting protein-protein interactions. BMC Bioinformatics (2004) 2.14
Practical population group assignment with selected informative markers: characteristics and properties of Bayesian clustering via STRUCTURE. Genet Epidemiol (2005) 2.09
ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer. J Clin Oncol (2003) 2.07
Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans. Am J Med Genet B Neuropsychiatr Genet (2003) 2.07
Pathway analysis using random forests classification and regression. Bioinformatics (2006) 2.01
Should the 7th edition of the lung cancer stage classification system change treatment algorithms in non-small cell lung cancer? J Thorac Oncol (2010) 2.00
Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J Neurosci (2008) 1.96
A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science (2004) 1.95
An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. Genome Biol (2014) 1.95
Bias detection and correction in RNA-Sequencing data. BMC Bioinformatics (2011) 1.93
Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. Immunity (2013) 1.88
Organ-specific expression of Arabidopsis genome during development. Plant Physiol (2005) 1.83
Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents. Hepatology (2011) 1.79
Geographic poverty and racial/ethnic disparities in cervical cancer precursor rates in Connecticut, 2008-2009. Am J Public Health (2012) 1.76
Rare nonsynonymous variants in alpha-4 nicotinic acetylcholine receptor gene protect against nicotine dependence. Biol Psychiatry (2011) 1.76
Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proc Natl Acad Sci U S A (2010) 1.73
A microarray analysis of the rice transcriptome and its comparison to Arabidopsis. Genome Res (2005) 1.71
A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology (2010) 1.71
Web GIS in practice VI: a demo playlist of geo-mashups for public health neogeographers. Int J Health Geogr (2008) 1.69
Relay ring-closing metathesis (RRCM): a strategy for directing metal movement throughout olefin metathesis sequences. J Am Chem Soc (2004) 1.69
Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells. Circulation (2012) 1.69
Two-stage designs in case-control association analysis. Genetics (2006) 1.65
AlzPharm: integration of neurodegeneration data using RDF. BMC Bioinformatics (2007) 1.65
Rare BRCA1 haplotypes including 3'UTR SNPs associated with breast cancer risk. Cell Cycle (2011) 1.64
Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage. Proc Natl Acad Sci U S A (2010) 1.60
Noninvasive analysis of the sputum transcriptome discriminates clinical phenotypes of asthma. Am J Respir Crit Care Med (2015) 1.58
Mining the structural genomics pipeline: identification of protein properties that affect high-throughput experimental analysis. J Mol Biol (2004) 1.57
MDA5 cooperatively forms dimers and ATP-sensitive filaments upon binding double-stranded RNA. EMBO J (2012) 1.57
The meiosis-specific zip4 protein regulates crossover distribution by promoting synaptonemal complex formation together with zip2. Dev Cell (2006) 1.57
Rapid generation of maturationally synchronized human dendritic cells: contribution to the clinical efficacy of extracorporeal photochemotherapy. Blood (2010) 1.56
SenseLab: new developments in disseminating neuroscience information. Brief Bioinform (2007) 1.56
Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples. Hum Mol Genet (2007) 1.55
X!!Tandem, an improved method for running X!tandem in parallel on collections of commodity computers. J Proteome Res (2007) 1.55
Analyzing cellular biochemistry in terms of molecular networks. Annu Rev Biochem (2004) 1.55
Haplotype-association analysis. Adv Genet (2008) 1.55
The impacts of errors in individual genotyping and DNA pooling on association studies. Genet Epidemiol (2004) 1.52
PathMAPA: a tool for displaying gene expression and performing statistical tests on metabolic pathways at multiple levels for Arabidopsis. BMC Bioinformatics (2003) 1.52
Genomic evidence for COP1 as a repressor of light-regulated gene expression and development in Arabidopsis. Plant Cell (2002) 1.52
Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion. J Virol (2009) 1.52
Regulation of a transient receptor potential (TRP) channel by tyrosine phosphorylation. SRC family kinase-dependent tyrosine phosphorylation of TRPV4 on TYR-253 mediates its response to hypotonic stress. J Biol Chem (2003) 1.50
Comparisons of multi-marker association methods to detect association between a candidate region and disease. Genet Epidemiol (2010) 1.50
Genome-wide association study of alcohol dependence implicates KIAA0040 on chromosome 1q. Neuropsychopharmacology (2011) 1.50
Susceptibility loci for murine HIV-associated nephropathy encode trans-regulators of podocyte gene expression. J Clin Invest (2009) 1.49
Age-related changes in reading systems of dyslexic children. Ann Neurol (2007) 1.49
FTO gene SNPs associated with extreme obesity in cases, controls and extremely discordant sister pairs. BMC Med Genet (2008) 1.48
Protein-DNA interaction mapping using genomic tiling path microarrays in Drosophila. Proc Natl Acad Sci U S A (2003) 1.46
Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease. Hum Mol Genet (2002) 1.44
A comparison of several methods for haplotype frequency estimation and haplotype reconstruction for tightly linked markers from general pedigrees. Genet Epidemiol (2006) 1.43
Molecular architecture of the chick vestibular hair bundle. Nat Neurosci (2013) 1.43
Human impacts have shaped historical and recent evolution in Aedes aegypti, the dengue and yellow fever mosquito. Evolution (2013) 1.42
Finding genetic contributions to sporadic disease: a recessive locus at 12q24 commonly contributes to patent ductus arteriosus. Proc Natl Acad Sci U S A (2002) 1.42
Evaluation of irinotecan plus paclitaxel in patients with advanced non-small cell lung cancer. Cancer Biol Ther (2005) 1.40
Analysis of far-red light-regulated genome expression profiles of phytochrome A pathway mutants in Arabidopsis. Plant J (2002) 1.40
VitaPad: visualization tools for the analysis of pathway data. Bioinformatics (2004) 1.39
Fine mapping of a seizure susceptibility locus on mouse Chromosome 1: nomination of Kcnj10 as a causative gene. Mamm Genome (2004) 1.39
Identifying projected clusters from gene expression profiles. J Biomed Inform (2004) 1.39
Analytical and clinical validity of whole-genome oligonucleotide array comparative genomic hybridization for pediatric patients with mental retardation and developmental delay. Am J Med Genet A (2008) 1.39
Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus. J Infect Dis (2011) 1.38
Detection of DNA copy number alterations using penalized least squares regression. Bioinformatics (2005) 1.38
Analysis of the mutational effects of the COP/DET/FUS loci on genome expression profiles reveals their overlapping yet not identical roles in regulating Arabidopsis seedling development. Development (2003) 1.38
MDA5 assembles into a polar helical filament on dsRNA. Proc Natl Acad Sci U S A (2012) 1.37
Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy. Virology (2009) 1.36
Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma. Arthritis Rheum (2006) 1.35
Pumilio 1 suppresses multiple activators of p53 to safeguard spermatogenesis. Curr Biol (2012) 1.34
Inferring protein-protein interactions through high-throughput interaction data from diverse organisms. Bioinformatics (2005) 1.33
On the use of DNA pooling to estimate haplotype frequencies. Genet Epidemiol (2003) 1.33
A genome-wide association study on obesity and obesity-related traits. PLoS One (2011) 1.33
Genome-wide association study identifies new susceptibility loci for posttraumatic stress disorder. Biol Psychiatry (2013) 1.32
PSMIX: an R package for population structure inference via maximum likelihood method. BMC Bioinformatics (2006) 1.32